We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $272M
1-Year Est. Return 30.95%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+30.95%
3 Year Est. Return
+75.66%
5 Year Est. Return
+99.24%
10 Year Est. Return
+591.34%
AUM
$348M
AUM Growth
-$7.67M
Cap. Flow
-$4.17M
Cap. Flow %
-1.2%
Top 10 Hldgs %
74.93%
Holding
62
New
–
Increased
2
Reduced
8
Closed
1

Top Buys

Rank Stock Value
1
PACB icon
Pacific Biosciences
PACB
+$119K
2
NVTA
Invitae Corporation
NVTA
+$23.4K

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$1.56M
2
AAPL icon
Apple
AAPL
+$1.22M
3
ADBE icon
Adobe
ADBE
+$944K
4
MSFT icon
Microsoft
MSFT
+$247K
5
ANVS icon
Annovis Bio
ANVS
+$231K

Sector Composition

Rank Sector Weight
1 Technology 39.46%
2 Healthcare 32.2%
3 Communication Services 12.12%
4 Consumer Discretionary 5.75%
5 Industrials 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADBE icon
1
Adobe
ADBE
$89.5B
$50.8M 14.58%
88,224
-1,500
-2% -$944K
IDXX icon
2
Idexx Laboratories
IDXX
$42.9B
$49.6M 14.24%
79,755
-2,325
-3% -$1.56M
MSFT icon
3
Microsoft
MSFT
$2.84T
$32.4M 9.3%
114,925
-850
-0.7% -$247K
AAPL icon
4
Apple
AAPL
$4.89T
$26.5M 7.59%
186,968
-8,295
-4% -$1.22M
BMY icon
5
Bristol-Myers Squibb
BMY
$127B
$21.6M 6.2%
364,972
– –
GOOG icon
6
Alphabet (Google) Class C
GOOG
$3.9T
$20.4M 5.85%
152,880
-500
-0.3% -$68.9K
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$3.91T
$18.6M 5.35%
139,520
– –
ISRG icon
8
Intuitive Surgical
ISRG
$121B
$17M 4.87%
51,195
-24
-0% -$8.06K
PACB icon
9
Pacific Biosciences
PACB
$422M
$14.1M 4.05%
552,850
+4,000
+0.7% +$119K
PAYX icon
10
Paychex
PAYX
$40.4B
$10.1M 2.9%
89,940
– –
CSCO icon
11
Cisco
CSCO
$450B
$10.1M 2.89%
185,288
-193
-0.1% -$10.8K
AMZN icon
12
Amazon
AMZN
$2.5T
$8.79M 2.52%
53,500
– –
UPS icon
13
United Parcel Service
UPS
$97.6B
$5.24M 1.5%
28,748
– –
PWR icon
14
Quanta Services
PWR
$93.9B
$5.17M 1.48%
45,400
– –
BKNG icon
15
Booking.com
BKNG
$138B
$4.95M 1.42%
52,125
– –
QCOM icon
16
Qualcomm
QCOM
$176B
$4.86M 1.39%
37,660
– –
TROW icon
17
T. Rowe Price
TROW
$25B
$3.65M 1.05%
18,557
– –
TSLA icon
18
Tesla
TSLA
$1.24T
$3.26M 0.93%
12,600
– –
NTR icon
19
Nutrien
NTR
$32.7B
$2.82M 0.81%
43,492
– –
ENB icon
20
Enbridge
ENB
$124B
$2.71M 0.78%
68,168
– –
JNJ icon
21
Johnson & Johnson
JNJ
$635B
$2.54M 0.73%
15,756
-100
-0.6% -$17.1K
NVTA
22
DELISTED
Invitae Corporation
NVTA
$2.41M 0.69%
84,700
+800
+1% +$23.4K
TMP icon
23
Tompkins Financial
TMP
$1.45B
$2.38M 0.68%
29,434
– –
T icon
24
AT&T
T
$165B
$2.35M 0.67%
115,256
– –
LHX icon
25
L3Harris
LHX
$55.9B
$2.13M 0.61%
9,690
– –
1
2 3

Similar funds

SC
Swan Capital Pensacola, Florida $272M AUM 14.84% 1-Year Est. Return
SC
Seldon Capital San Francisco, California $272M AUM 90.68% 1-Year Est. Return
AGP
Autumn Glory Partners Dallas, Texas $272M AUM 20.37% 1-Year Est. Return
SFPG
Stonebridge Financial Planning Group Orlando, Florida $272M AUM 16.91% 1-Year Est. Return
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
SS
Spinecap SAS Paris, France $272M AUM 23.45% 1-Year Est. Return
LAM
Lountzis Asset Management Wyomissing, Pennsylvania $273M AUM 19.71% 1-Year Est. Return

Bourne Lent Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Bourne Lent Asset Management held 62 positions worth $348M, down 2.2% from $356M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 1.6%. Bourne Lent Asset Management opened no new positions and exited 1, leaving the 62-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 39% a quarter earlier, followed by Healthcare and Communication Services.

  • Bourne Lent Asset Management added most to Pacific Biosciences in Q3 2021, an estimated $119K increase.
  • Bourne Lent Asset Management's biggest Q3 2021 reduction was Idexx Laboratories, cutting an estimated $1.56M.
  • Bourne Lent Asset Management fully exited Annovis Bio in Q3 2021, selling an estimated $231K.
  • Bourne Lent Asset Management's ten largest holdings make up 75% of its $348M portfolio in Q3 2021.
  • Bourne Lent Asset Management opened 0 new positions and closed 1 in Q3 2021.
  • Bourne Lent Asset Management's portfolio value fell 2.2% quarter-over-quarter to $348M.

Based on Bourne Lent Asset Management's 13F filing for Q3 2021, filed 20 Oct 2021.